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Abstract
Objective: This study aims at exploring the effects of sodium tungstate treatment on hypothalamic plasticity, which is
known to have an important role in the control of energy metabolism.
Methods: Adult lean and high-fat diet-induced obese mice were orally treated with sodium tungstate. Arcuate and
paraventricular nuclei and lateral hypothalamus were separated and subjected to proteomic analysis by DIGE and mass
spectrometry. Immunohistochemistry and in vivo magnetic resonance imaging were also performed.
Results: Sodium tungstate treatment reduced body weight gain, food intake, and blood glucose and triglyceride levels.
These effects were associated with transcriptional and functional changes in the hypothalamus. Proteomic analysis revealed
that sodium tungstate modified the expression levels of proteins involved in cell morphology, axonal growth, and tissue
remodeling, such as actin, CRMP2 and neurofilaments, and of proteins related to energy metabolism. Moreover,
immunohistochemistry studies confirmed results for some targets and further revealed tungstate-dependent regulation of
SNAP25 and HPC-1 proteins, suggesting an effect on synaptogenesis as well. Functional test for cell activity based on c-fos-
positive cell counting also suggested that sodium tungstate modified hypothalamic basal activity. Finally, in vivo magnetic
resonance imaging showed that tungstate treatment can affect neuronal organization in the hypothalamus.
Conclusions: Altogether, these results suggest that sodium tungstate regulates proteins involved in axonal and glial
plasticity. The fact that sodium tungstate could modulate hypothalamic plasticity and networks in adulthood makes it a
possible and interesting therapeutic strategy not only for obesity management, but also for other neurodegenerative
illnesses like Alzheimer’s disease.
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Introduction
Western countries are currently facing a dramatic increase in
the incidence of metabolic diseases, including obesity and type-2
diabetes. In basic terms, obesity develops when energy intake
exceeds energy utilization, breaking the energy balance [1].
Deciphering biological mechanisms that control food intake and
energy homeostasis could help find a way to stop the epidemic. In
healthy animals, food intake is permanently adjusted to fit
cumulative energy expenditure. This energy homeostasis is finely
tuned by endocrine and neural mechanisms. In this regard,
specific brain areas sense modifications in peripheral metabolic
parameters, such as blood glucose, free fatty acids, and circulating
insulin and leptin levels, and elicit appropriate behavioral and
autonomic responses.
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The hypothalamus is highly involved in this physiologic
feedback. This diencephalic structure contains distinct nuclei,
among which arcuate (ARC), lateral (LHA) and paraventricular
(PVN) nuclei have key roles in the control of energy homeostasis
[2]. The ARC contains at least two neuronal subpopulations
controlling energy balance, which are components of a highly
structured hypothalamic network [3] and project to other
hypothalamic areas, such as PVN and LHA [4,5]. This
organization is essential for the long-term maintenance of energy
homeostasis, as well as aberrant hypothalamic development, which
especially affects neuronal projections from ARC to PVN, and is
associated with a predisposition to diet-induced obesity [6]. In
addition, impaired connectivity in specific neuronal networks
located within the ARC could be one reason for hyperphagia in
leptin-deficient mice [7].
Interestingly, the hypothalamus remains ‘‘plastic’’ in adulthood,
meaning that neuronal networks in this structure can undergo
functional or morphological remodeling. Recently, it has been
shown that some metabolic signals could act as trophic factors to
induce not only the organization of the hypothalamus during
development [8], but also its continuous re-organization in adult
mice [7,9]. On the contrary, excessive caloric intake may be a
negative signal for neuronal plasticity in adulthood, while caloric
restriction potentiates remodeling of brain areas [10]. These
observations enhance the idea of neuronal plasticity as a central
player to maintain brain circuitry for the adequate regulation of
energy balance [11].
Sodium tungstate is a neutral salt of tungsten. In aqueous
solution it acts as a phosphatase inhibitor, changing the catalytic
activity of these enzymes [12,13]. Several animal studies have
highlighted the possible role of sodium tungstate in regulating
different aspects of energy homeostasis in rodents [14,15]. We
have demonstrated that sodium tungstate also plays an important
role in the hypothalamus, activating leptin’s pathway [16] and
regulating the gene expression of the main neuropeptides involved
in the control of food intake: neuropeptide Y (NPY), agouti related
peptide (AgRP) and proopiomelanocortin (POMC) [14]. Further-
more, it has been described that sodium tungstate can inactivate
glycogen synthase-3b (GSK3b) (a kinase that hyperphosphorylates
tau in Alzheimer’s disease) in neuroblastoma cells and in the rat
cerebral cortex [17], showing its involvement in other neurological
areas.
Here, we investigated whether a chronic treatment with sodium
tungstate can rewire hypothalamic networks, which may be
involved in restoring eating behavior and improving the peripheral
metabolism of obese animals. For this purpose, we first analyzed
the molecular signature of hypothalamic plasticity after tungstate
administration through proteomic and immunohistochemistry
analyses of different hypothalamic nuclei from mice. We then
scanned the brains of mice after tungstate administration using
magnetic resonance imaging to explore a putative tungstate-
related structural plasticity.
Materials and Methods
Animals, Surgery and Drug Administration
All animal experiments were carried out in accordance with the
European Communities Council directive (86/609/EEC) and the
practical guide for the care and use of laboratory animals
published by the Spanish National Research Council, which
specifically approved this study. For this study, 8-week-old male
C57BL6/J mice and 8-week-old male C57BL6/J diet-induced
obesity (DIO) mice (fed with a high-fat diet from weaning) (Harlan
laboratories, Indianapolis, IN, USA) were used. The animals were
kept in a temperature-controlled room (2261uC) on a 12-h light-
dark cycle with free access to food and water. In accordance with
the experiments, mice were fed with either a standard diet (22.4%
fat, 60.9% carbohydrate and 16.7% protein; 2.9 Kcal/g; R04T25,
Safe, France) or a high-fat diet (60% fat, 20% carbohydrate and
20% protein; 5.24 Kcal/g; D12492, Research Diets, New
Brunswick, NJ, USA). Between 10–12 weeks of age, half of the
lean and DIO mice groups were treated with 2 g/l sodium
tungstate (Na2WO4X2H2O; Sigma-Aldrich, St. Louis, MO, USA)
in drinking water for 14 days. The calculated average dose was
130 mg/kg/day (water intake per day 2.6 ml regardless of the
group). During the entire experimental period, water intake, food
intake, and body weight of all animals were periodically recorded.
For tissue collection, mice were killed by decapitation. Brains were
quickly removed and hypothalamus dissected. 12-week-old male
Wistar rats (Charles River Laboratories, Sta. Perpe`tua de la
Mogoda, Spain) were used for intracerebroventricular injections
(icv) as previously described [16].
Hypothalamus Dissection and Nucleus Enrichment
Brains were immersed for 10 min in 2 ml of ice-cold
preservative medium (200 mM sucrose, 28 mM NaHCO3,
2.5 mM KCl, 7 mM MgCl2, 1.25 mM NaH2PO4, 0.5 mM
CaCl2, 1 mM L-ascorbate, and 8 mM D-glucose, pH 7.4),
complemented with a 10% anti-protease cocktail (Complete Mini,
Roche Diagnostics, Indianapolis, IN, USA). Hypothalamus
dissection and nucleus enrichment were performed as previously
described [18]. In brief, 0.5 mm slices using a vibrating microtome
were prepared and placed in ice-cold preservative medium. From
bregma 20.46 to 22.46, different nuclei were identified and cut,
and pieces were then put into separate microcentrifuge tubes and
stored at 280uC. Mean tissue weights were 3 mg for ARC and
PVN and 6 mg for LHA, respectively.
Hypothalamic Nucleus Proteomics and DIGE Analyses
DIGE analyses of hypothalamic nuclei were performed as
previously described [19]. Samples were taken from the following
groups: untreated lean animals (UL) (n = 4); lean animals treated
with sodium tungstate (TL) (n = 4); untreated obese animals (UO)
(n = 4); and obese animals treated with sodium tungstate (TO)
(n = 4). These samples were homogenized in a buffer containing
7 M urea, 2 M thiourea, 2% (w/v) CHAPS, 65 mM DTT, 0.5%
(v/v) IPG buffer, and 10 mM sodium orthovanadate. Proteins
were extracted for 30 min at 4uC, and lysates were clarified by
centrifugation at 14000 rpm at 4uC for 30 min. Protein extracts
were precipitated using a 2D clean-up kit (GE Healthcare,
Pollards Wood, United Kingdom) and resuspended in a buffer
containing 30 mM Tris, 7 M urea, 2 M thiourea, 4% CHAPS,
pH 8.5. Finally, protein content was quantified using an RC DC
protein assay kit (Bio-Rad, Hercules, CA, USA). Samples were
minimally labeled with Cy3 or Cy5 fluorescent dyes (50 mg of
protein/400 pmol of dye) during 30 min at 4uC and multiplexed,
as described in table S1. An internal standard (pool from all the
samples present) labeled with Cy2 was included in each gel. 2D
electrophoresis was performed using IPG strips pH 3–10 as the
first dimension and 10% acrilamide as the second dimension.
Fluorescence images of the gels were acquired on a Typhoon 9400
scanner (GE Healthcare). Cy2, Cy3, and Cy5 images for each gel
were scanned at 488/520-, 532/580-, and 633/670-nm excita-
tion/emission wavelengths, respectively, at 100-mm resolution.
Image analysis was performed using DeCyder version 6.5 software
(GE Healthcare).
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Protein Digestion, Mass Spectrometry, Protein
Identification and Analysis
The same gels used for DIGE analyses were used as preparative
gels and were silver-stained using an MS-compatible protocol [20].
Differentially expressed proteins were selected, excised from the
different gels silver stained, and in-gel digested with trypsin at
37uC overnight (Promega, Madison, WI, USA). Peptide extraction
was performed, and ZipTip concentrating and desalting was done
as described previously [21,22]. Peptides were analyzed in a
MALDI-TOF/TOF 4700 Proteomics Analyzer (Applied Biosys-
tems, Foster City, CA, USA) in the reflector/delayed extraction
mode, and ESI-Q-TOF Global (MicromasS, Cary, NC, USA).
Peptide masses from MS analyses and their fragments obtained
from MS/MS spectra were combined and submitted to Sequence
Query Mascot software (Matrix Science, Boston, MA, USA).
Searches were performed using Swiss-Prot as the database and
mammals as taxonomy. Error tolerated was 0.07-Da for peptide
mass, 0.8-Da for fragment mass (MS/MS), and a single trypsin
missed cleavage. Proteins were considered identified when they
had a significant (p,0.05) Mascot score. Ingenuity Pathways
Knowledge Base was used to analyze the predominant interaction
networks and high-level functions of differentially expressed
proteins (www.ingenuity.com).
1D and 2D Western Blots
For 2D gels, samples were homogenized in 7 M urea, 2 M
thiourea, 2% (w/v) CHAPS, 65 mM DTT, 0.5% (v/v) IPG buffer,
and 10 mM sodium orthovanadate and were quantified. 50 mg
were then loaded on IPG strips (7 cm, pH 3–10) and run on a
Protean IEF cell at 7300 V/h. The second dimension was run as
described previously [23] in 10% acrylamide gels. For 1D gels
from brain proteins, protein isolation was performed in a protein
lysis buffer containing: Hepes 10 nM; KCl 10 nM; Sucrose
240 mM; EDTA 2 mM; DTT 0.5 mM; phosphatase inhibitors
(sodium orthovanadate 10mM, PMSF 0.5mM, and sodium
pyrophosphate 149 mM); and 16 protease inhibitor cocktail
(Sigma-Aldrich). Tissues were homogenized and centrifuged, and
supernatants were collected. Proteins were quantified and
subjected to separation in an 8% acrylamide gel. All gels were
transferred to polyvinylidene fluoride (PVDF) membranes at
100 V for 1 h 30 minutes, and probed with 1/1000 dilution of
rabbit anti-pCRMP-Thr514, anti-CRMP2, anti-Phospho-p44/42
MAPK, anti-pSTAT3-Y705 (Cell signalling, Beverly, MA, USA),
and anti-beta actin (Sigma-Aldrich).
Immunohistochemistry, Analysis, and Quantification of
Staining Intensity
Animals were anesthetized and transcardially perfused with
15 ml of cold PBS with 0.1% heparin followed by 50 ml of cold
4% (w/v) paraformaldehyde in PBS. Brains were carefully
removed from the skull and soaked overnight in the fixative
solution (4% buffered paraformaldehyde), 24 h on glucose 30%-
containing 16PBS, dehydrated-deffated, and embedded in paraf-
fin. Tissue blocks were cut into 5-mm coronal sections using a
rotating microtome and were serially collected. Representative
sections, 1 among 10, containing ARC were selected for
immunohistochemical analysis. To reduce nonspecific reactions,
sections were incubated for 20 min in a blocking solution of 10%
normal donkey serum (Jackson Immunoresearch Laboratories,
West Grove, PA, USA) in PBS with 0.5% Triton X-100. The
sections were incubated overnight with primary antibodies: c-fos,
syntaxin 1A (HPC-1) 1:100 (Santa Cruz Biotechnology, Santa
Cruz, CA, USA); b-tubulin 1:200, synaptosomal-associated
protein 25 (SNAP-25) 1:100, collapsing response mediator protein
2 (CRMP2) 1:50 (Abcam, Cambridge, United Kingdom); glial
fibrillary acidic protein (GFAP) 1:100 (Sigma-Aldrich); and
neurogenic differentiation factor 1 (NeuroD1) 1:200 (Chemicon,
Temecula, CA, USA). Each section was incubated for 2 hours in
the secondary antibody, biotinylated anti-goat made in donkey
IgG 1:100 (Jackson Immunoresearch Laboratories). Finally, the
sections were incubated in 1 mg/ml streptavidin Alexa Fluor 555
conjugates (Molecular Probes, Invitrogen, Carlsbad, CA, USA) in
PBS with 0.5% Triton X-100. Preparations were then placed
under cover slips using a water-based mounting agent for
fluorescent preparations (Vectashield, Vector, Burlingame, CA,
USA). Images were analyzed using the computer-assisted image
analysis program ImageJ (developed and maintained by the
National Institutes of Health, Bethesda, MD, USA) and a set of
customized macros. The overall immunofluorescence labeling was
standardized for an accurate quantification of the staining
following the methods of Taylor and Levenson [24]. To account
for variations in staining intensity due to immunohistochemical
methods, intensity was normalized in the range of 0 to 255.
Counting of positive cells was performed at a magnification of 406
by the same experimenter who was blinded to the animal
treatment. Two different sections of the ARC per animal,
anatomically matched across all animals studied and distributed
between Bregma 21.06 and 22.06, were counted and summed to
give one number per animal.
Magnetic Resonance Imaging (MRI)
MRI experiments were conducted on a 7.0 T BioSpec 70/30
horizontal animal scanner (Bruker BioSpin, Ettlingen, Germany),
equipped with a 12 cm inner diameter actively shielded gradient
system (400 mT/m). The receiver coil was a phased array surface
coil for mouse brain. Animals were placed in a supine position in a
plexiglas holder with a nose cone for administering anaesthetic
gases (isofluorane in a mixture of 30% O2 and 70% CO2) and
were fixed using a tooth bar, ear bars and adhesive tape. Tripilot
scans were used for accurately positioning the animal’s head in the
isocenter of the magnet. Diffusion Tensor Imaging (DTI)
acquisition was performed by using an echo planar imaging
(EPI)-based DTI sequence, applying TR = 6000 ms,
TE = 32.11 ms, 4 segments, 3 averages, b-value = 1000, 30
different diffusion directions, 5 A0 images, slice thickness = 1 mm,
number of slices = 14, FOV = 1.561.560.9 mm3, and matrix
size = 1286128618 pixels, which resulted in a spatial resolution
of 0.1260.12 mm in 0.5 mm slice thickness.
DTI maps of tensor diffusivity, fractional anisotropy (FA), main
diffusivity (MD), axial diffusivity (l1) and radial diffusivity (l2+ l3/
2) were calculated using Paravision 5.0 software (Bruker Biospin),
and custom programs written in MATLAB (The MathWorks,
Inc., Natick, MA, USA), as previously described [25,26]. Regions
of interest (ROI) were individually drawn for each subject by an
experienced neurobiologist blinded to the treatments, overlaying
the MRI images with the digital Paxinos and Watson rat brain
atlas. The PVN region was drawn at 20.82 and 21.32 mm from
Bregma, and ARC was drawn at 21.46 and 21.96 mm from
Bregma. The mean values of ROIs for each diffusion index and
nucleus calculated were considered for statistical analysis.
Statistical Analysis
Data are presented as mean6SEM. A one-way analysis of
variance followed by Tukey’s multiple-comparison test was used to
assess the statistical difference between groups. When appropriate,
an unpaired t-test was performed.
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Results
Sodium Tungstate Effects on Metabolic Parameters
C57Bl6 mice were divided into 4 groups: untreated lean mice
(UL); lean mice treated with sodium tungstate (TL); untreated
Figure 1. In vivo sodium tungstate effects. Mice were treated with
2 g/l of sodium tungstate in water for 14 days. Body weight gain (A)
and food intake (B) were measured for the duration of treatment, and
blood glucose (C) and TG (D) were measured at the beginning and at
the end of treatment. Open squares correspond to untreated lean mice
(UL) (n = 6), black squares to treated lean mice (TL) (n = 6), open circles
to untreated obese mice (UO) (n = 6), and black circles to treated obese
mice (TO) (n = 6). In the bar graph, white and black bars represent
untreated and treated animals, respectively. *p,0.05; **p,0.01;
***p,0.001 vs. lean mice. +++p,0.001 treated lean vs. untreated lean
mice. #p,0.05; ###p,0.001 treated obese vs. untreated obese mice.
Data are the mean6SD.
doi:10.1371/journal.pone.0039087.g001
Figure 2. Representative 2D gels from hypothalamic nuclei.
Hypothalamic nuclei were isolated and subjected to 2D gel electro-
phoresis, with the first dimension being the pI from 3 to 10, and the
second dimension being the MW resolved in a 10% acrylamide gel. Spot
profile analysis was performed using DeCyder software. (A) Represen-
tative 2D gels from each hypothalamic nucleus. pI increased from left to
right, and MW decreased from top to bottom. All spots exhibiting
significant differences (numbered) were selected for protein digestion
mass spectrometry, and protein identification summarized in table S1.
As an example, a close-up image of differentially expressed proteins
between untreated and treated obese mice is shown in (B).
doi:10.1371/journal.pone.0039087.g002
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obese mice (UO); and obese mice treated with sodium tungstate
(TO). Before sodium tungstate treatment, the obese groups had a
significantly higher body weight (data not shown) as compared
with the lean animals, and, from the second day of treatment
onward, the treated groups showed a significant reduction in body
weight gain, maintaining this difference for the entire duration of
treatment (Fig. 1A). From the fourth day onward, a significant
reduction in food intake in the treated groups was also recorded
(Fig. 1B) and maintained for the entire duration of treatment, with
no variation in water intake (data not shown). Blood glucose and
triglyceride levels were measured before and after treatment. A
significant reduction in the values was observed in the obese
treated animals (Fig. 1C). The effects of sodium tungstate observed
here have been widely described in different models of obesity
[14,15,19,27].
Oral Administration of Sodium Tungstate Modifies the
Protein Profile of the Different Hypothalamic Nuclei
We have previously demonstrated that sodium tungstate
regulated neuropeptide gene expression in the hypothalamus
and neural cells [14,28]. Therefore, protein expression levels
would also be modified using this treatment. To assess whether
sodium tungstate could change protein profile expression in the
hypothalamus, we performed proteomic analyses of each hypo-
thalamic nucleus individually (ARC, PVN, and LHA).
2D-DIGE gels from the UL, TL, UO, and TO groups of
animals were done for each nucleus, and spots were analyzed with
DeCyder software. All proteins showing significant differences
(p,0.05) between compared groups (UL vs UO; UL vs TL; and
UO vs TO) were selected (Fig. 2A and close-up images Figure 2B)
and picked up to be identified by mass spectrometry. Table 1
shows all identified proteins modified by sodium tungstate. A
complete list of protein identification is provided in table S1.
Analysis of this list highlighted that an important part of the
proteins modified by treatment could be classified into three
general groups of functions, independently of the nucleus analyzed
or the phenotype (lean or obese). These groups of proteins were
involved in axonal growth and neuronal plasticity (i.e. alpha-
Table 1. Tungstate targets identified by proteomics in
different hypothalamic nuclei.
Spota Uniprot Protein Phenotypeb Ratioc P Nuclei
Axonal growth and neuronal
plasticity
213 O08553 CRMP2 L 1.61 0.011 ARC
215 O08553 CRMP2 L 1.34 0.012 ARC
244 O08553 CRMP2 L 21.19 0.031 ARC
297 P46660 Alpha-internexin L 21.8 0.024 ARC
62 P08553 NEFM O 1.5 0.037 ARC
1475 P03995 GFAP O 1.21 0.017 ARC
242 O08553 CRMP2 L 1.34 0.021 PVN
278 P46660 Alpha-internexin O 21.1 0.022 PVN
217 O08553 CRMP2 L 21.32 0.061 LHA
219 O08553 CRMP2 L 21.41 0.029 LHA
224 O08553 CRMP2 L 21.61 0.006 LHA
176 O08553 CRMP2 O 1.19 0.059 LHA
Cytoskeleton and neuronal structure
1475 P60710 Beta-actin O 1.21 0.017 ARC
1559 P60710 Beta-actin O 1.63 0.028 ARC
1058 Q8BXF8 Actin-related
protein M1
O 21.21 0.047 ARC
1224 P68369 Alpha-tubulin,
chain 1A
O 1.61 0.013 ARC




L 21.21 0.044 ARC
479 P14152 Malate
dehydrogenase
L 1.2 0.027 ARC
1419 P17182 Enolase 1 L 1.36 0.04 ARC
1224 Q8BKZ9 Pyruvate
dehydrogenase
O 1.61 0.013 ARC
277 Q9DCT2 NADH
dehydrogenase
L 1.72 0.015 PVN
329 Q9DCT2 NADH
dehydrogenase
L 1.32 0.02 PVN
303 P17751 Triosephosphate
isomerase
O 21.82 0.023 PVN
567 Q811J3 Aconitase 2 O 21.77 0.034 PVN
359 Q00623 Apolipoprotein A-I O 21.6 0.002 PVN
431 Q04447 Creatine kinase B L 1.14 0.003 ARC
361 P21550 Enolase 3 L 21.21 0.028 LHA
373 P17182 Enolase 1 L 21.62 0.05 LHA
518 P14152 Malate
dehydrogenase
L 21.21 0.023 LHA
664 Q9D051 Pyruvate
dehydrogenase-b
L 21,42 0,049 LHA
230 P52480 Pyruvate kinase O 1.43 0.015 LHA
1475 Q04447 Creatine kinase B O 1.21 0.017 ARC
648 P35486 Pyruvate
dehydrogenase-a
O 1.61 0.059 LHA
Others
98 P48722 Hspa 4L L 1.19 0.021 ARC
1604 Q9Z2Q6 Septin-5 L 1.33 0.036 ARC
Table 1. Cont.
Spota Uniprot Protein Phenotypeb Ratioc P Nuclei
1224 P62814 Vacuolar H+ATPase
B2
O 1.61 0.013 ARC
1058 P31938 MEK1 O 21.21 0.047 ARC
141 P50518 V- ATPase E1 L 21.17 0.046 PVN
242 P50516 V-ATPase A L 1.34 0.021 PVN
329 P70202 Latexin L 1.32 0.02 PVN
428 Q9R0Y5 Adenilate kinase 1 O 21.77 0.009 PVN
559 P09671 Superoxide
dismutase
O 21.21 0.047 PVN
149 P63017 Hspa8 L 21.51 0.052 LHA
664 P62880 Gnb 2 L 21.42 0.049 LHA
aSpot numbers corresponding to 2D images for each type of nuclei (Figure 2).
bMice phenotypes: L = lean. O = obese.
cRatios of protein expression levels calculated using DeCyder software as the
fold change in normalized spot volume comparing tungstate treated and non
treated animals (Student’s t test based on the log of the ratio of the treated
group to the control group).
doi:10.1371/journal.pone.0039087.t001
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internexin), cytoskeleton and neuronal structure (i.e. b-tubulin)
and energy metabolism (i.e. pyruvate dehydrogenase).
Sodium Tungstate Modifies the Expression of Proteins
Involved in Neuronal Plasticity and Axonal Growth
Some proteins belonging to the neurofilament family were
identified in the hypothalamus of the treated animals (Table 1):
alpha-internexin (INA), neurofilament medium polypeptide
(NEFM), and GFAP. All of these proteins are important
components of myelinated axons. Using Ingenuity Pathways Knowl-
edge Base to identify local networks between experimental proteins
and interactions with other proteins in the knowledge base, we
defined a strong relationship between NEMF/GFAP and mitogen-
activated protein kinase/signal transducer and activator of
transcription 3 (MAPK/STAT3) (Fig3A). We further established
that sodium tungstate, when centrally administered in the third
ventricle, increased the phosphorylation of MAPK and STAT3 in
the hypothalamus (Fig. 3B and [28]), confirming the connection
between these two proteins and sodium tungstate effects.
Supporting the theory that sodium tungstate could be involved
in neuronal structure, another protein implicated in these
processes was identified in our analyses, namely CRMP2. CRMP2
was detected in all hypothalamic nuclei analyzed (ARC, PVN, and
LHA), and under all different treatment conditions (Table 1,
Fig. 4A). This protein binds to tubulin heterodimers to promote
microtubule assemblage and cytoskeleton remodeling [29], and it
is regulated by phosphoinositide-3 kinase (PI3K), MAPK, and
GSK3b [30,31,32], proteins which are also modulated by sodium
tungstate [33,34,35].
Further analysis of the 2D gels showed that all CRMP2 proteins
detected corresponded to different spots (Fig. 4A), suggesting
multiple posttranslational modifications. To confirm that proteins
identified by mass spectrometry actually corresponded to CRMP2,
2D Western blot was performed and total CRMP2 detected
(Fig. 4B). The results confirmed the identity of the proteins as
CRMP2 (Fig. 4B) and also enabled us to see that there were many
more spots corresponding to this protein than originally detected
in the 2D gels. The membrane was incubated with pCRMP2-T514
antibody (Fig. 4C), and results showed that phosphorylation took
place in many spots. This great pI variability could demonstrate
that the spots detected in 2D-DIGE gel (Fig. 4D) represent hypo-
or hyper-phosphorylated forms of CRMP2, corresponding to basic
and acidic pI, respectively and sodium tungstate treatment
modulates them (Fig. 4D, spot 217 basic pI decreased and spot
215 acidic pI increased).
Finally, proteomic analysis also showed changes in b-actin, a-
tubulin, and b-tubulin (Table 1), all of which are related to the
cytoskeleton and to neuronal structure and polarity [36].
Involvement of Sodium Tungstate in Plasticity-related
Reorganization in the ARC Nucleus
Further evidence of the effects of sodium tungstate on synaptic
plasticity in the hypothalamus was provided by immunohisto-
chemistry studies. There were very few c-fos immunoreactive cells
in the ARC of non-treated animals, with no differential expression
in the UL and UO animals, as in previous findings [37]. In
contrast, the overall number of c-fos immunoreactive cells in the
ARC of the treated animals was significantly higher (Fig. 5A).
Sodium tungstate also induced morphological modifications in
ARC astroglia with changes in the expression and distribution of
GFAP, a marker of intermediate filaments in glial cells. The
number and size of astroglial profiles in the ARC neuropil
exhibited a significant increase (Fig. 5B), which could be related to
changes in neuronal coverage through astrocytes and changes in
the communication between them. Furthermore, from the list of
potential factors identified in our proteomic study, we selected
three markers related to axonal growth and neuronal plasticity. In
particular, we chose a microtubule protein that has an important
role in synaptic plasticity (b-tubulin), CRMP2, and HPC-1 (this
last one extracted from Ingenuity Pathways analyses, data not
shown). In addition, synaptosomal-associated protein 25
(SNAP25), a synaptic protein involved in the regulation of
neurotransmitter release, and NeuroD-1, a neurogenic transcrip-
tion factor involved in plasticity-related reorganization, were also
selected for immunohistochemistry studies. Upon quantification of
all data, our results showed a reduced expression of b-tubulin
(Fig. 5C) and HPC-1 (Fig. 5D) in the ARC of the treated animals,
together with an increased expression of NeuroD1 (Fig. 5e) and
SNAP25 (Fig. 5F). For total-CRMP2, no clear differences in
expression were observed in the treated versus non-treated
animals. However, we discovered that the intensity of the
immunoreactivity was lower around some ARC neurons in the
animals treated with sodium tungstate (data not shown).
All these results suggest that sodium tungstate induces structural
and functional remodeling in hypothalamic circuits and that
sodium tungstate could be involved in the refinement of ARC
circuitry.
Sodium Tungstate Modifies the PVN Microstructure
Finally, to further characterize the effect of sodium tungstate
treatment on the hypothalamus, we performed magnetic reso-
nance assays in vivo, comparing the ARC and PVN between lean
animals treated with sodium tungstate and lean non-treated
animals. MRI measures the random diffusional motion of water
molecules and provides quantitative indices of the structural
features of tissue in central nervous system. DTI is the most
promising MRI technique to image changes in white and grey
matter integrity, due to their ability to non-invasively assess tissue
water diffusion. Different parameters related to brain microstruc-
ture can be obtained from DTI images, namely fractional
anisotropy (FA), main diffusivity (MD), axial diffusivity (AD) and
radial diffusivity (RD) [38,39,40]. There were no significant
differences in FA values, neither in the ARC nor in the PVN
(Fig. 6a). On the contrary, the treatment produced a significant
decrease in MD (Fig. 6b), AD (Fig. 6c), and RD (Fig. 6d) in the
PVN. However, no significant effects of treatment on MD, AD or
RD in the ARC were observed.
These results show a decrease in the movement of water
molecules in the PVN, probably due to a higher degree of
neuronal organization in the PVN after treatment.
Figure 3. Sodium tungstate effects on the neurofilament protein family. (A) Ingenuity Pathways analysis: representative analysis of ARC
identified proteins in obese mice (for protein details, see table S1). The network consists of 35 nodes and includes 9 differentially expressed proteins
identified by our MS/MS spectra (in red). Note the interactions of GFAP and NEFM (discontinuous circles) with MAPK and STAT3 (black circles). All the
identified proteins appeared in the network map. (B) Representative western blot of hypothalamic proteins taken from rats fasted for 8 h, and treated
with 10 mg of sodium tungstate (W) via icv (n = 6), and western blot quantification. Tissues were collected 5 and 15 min after treatment. *p,0.05 vs.
untreated rats. The leptin signaling pathway was activated in the hypothalamus of sodium tungstate-treated animals as soon as 5 minutes after icv
injection, showing changes in the phosphorylation state of STAT3 and MAPK, in accordance with Ingenuity Pathways results.
doi:10.1371/journal.pone.0039087.g003
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Figure 4. Sodium tungstate has an effect on the CRMP2 protein. An important portion of all spots isolated were identified as CRMP2. (A)
Representative ARC 2D gel from treated lean mouse. Insert image shows different CRMP2 proteins. Numbers correspond to identification of CRMP2
by mass spectrometry. (B) Protein identification using mass spectrometry was verified performing 2D-Western blot (insert image). Spots identified as
CRMP2 by mass spectrometry co-localized perfectly with those identified by 2D-western blot, confirming that identification had been performed
correctly. (C) p-CRMP2T514 antibody reveals that a significant number of posttranslational changes of this protein involve phosphorylation, and the
great pI variability indicates that multiple posttranslational changes occur all at once. (D) Representative close-up images of spots with different pI
corresponding to CRMP2.
doi:10.1371/journal.pone.0039087.g004
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Discussion
Previous results from our group suggested that sodium tungstate
could have direct effects on the central nervous system in rodents,
which could partly explain its antiobesity effects [14,28]. In this
report, we thoroughly analyze the effects of sodium tungstate on
the hypothalamus, specifically on protein expression, using for this
purpose a technique capable to analyze proteins in depth:
proteomic analysis.
Results comparing lean and obese animals (non-treated) showed
that there were few differences between these two groups,
indicating no major variations on protein profile in the hypotha-
lamic nuclei. This fact could be explained by the rapid changes
described at the protein level during the initial phase of a high-fat
diet (HFD) [41]. Thus, hypothalamic neurons quickly become
insulin-resistant, even before animals exhibit a diabetic or obese
phenotype [42]. Later on, an adaptive process is triggered and
could explain these few differences obtained in our model.
Results comparing treated and non-treated animals showed
that sodium tungstate had similar effects on each of the
hypothalamic nuclei analyzed (ARC, PVN, and LHA) and on
each mouse phenotype (lean or obese), acting principally on
proteins involved in energy metabolism, axonal growth, and
neuronal plasticity. As described in earlier studies [21,43,44],
sodium tungstate treatment modulates energy homeostasis in
peripheral tissues, with the observed changes not surprisingly also
in hypothalamic nuclei. Therefore, we proceeded to focus on the
potential effects of the drug on neuronal plasticity, which are less
commonly known.
The neuron is one of the most highly polarized cells known,
having two structurally and functionally distinct parts, the axon
and the dendrites [45]. Elongation of immature neurites is
necessary for axon specification. Intracellular mechanisms that
help to enhance neurite/axon outgrowth evidently require
reorganization of the cytoskeleton, including acting filaments
and microtubules [36]. Proteomic and immunohystochemistry
results showed that sodium tungstate has significant effects on the
neurofilament protein family, essential for the maintenance of
neuronal structure [46,47,48], and proteins related to cytoskele-
ton, neuronal structure, and polarity [36], such as b-actin, a-
tubulin, and b-tubulin. The function of the neurofilament family of
proteins is regulated by MAPK and STAT3. We have demon-
strated that sodium tungstate regulates both factors in the
hypothalamus, as shown by our icv studies, and in other tissues
[28,34]. GFAP, a characterized marker of intermediate filaments
in glial cells, is also regulated by sodium tungstate, as seen in
proteomic and immunohistochemistry studies. These findings
suggest that the observed changes involve not only ARC neurons
but also other neuronal components, such as glial cells. This
highlights the importance of the communication between different
cell types in order to sustain plastic changes under certain
physiological and pathological conditions. In fact, attributing the
plasticity of glial cells to their heterogeneity and their delicate
sensitivity to neuronal activity and synaptic transmission [49,50], it
is then possible to hypothesize that glial cells could play central
roles in the effectiveness of sodium tungstate in reducing body
weight gain.
CRMP2 is another key protein for neuronal structure. It is
involved in axonal growth and the guidance of immature neurons
[51,52]. Many evidences also support its implication in the
pathogenesis of Alzheimer’s disease [53,54,55]. Sodium tungstate
plays an important role in CRMP2 regulation, as it induced
changes at the post-translational level in all hypothalamic nuclei
and mouse phenotypes analyzed, although no changes in total
protein were observed in immunohistochemistry studies. CRMP2
is regulated by Pi3K, MAPK, and GSK3-b [30,31,32], all of
which are regulated, in turn, by sodium tungstate [33,34,35].
Therefore, even though further studies on the specific effects of
sodium tungstate on CRMP2 activity and post-translational
modifications are needed, here we establish a strong relationship
between them.
The immunohistochemistry results with b-tubulin, HPC-1,
NeuroD1 and c-fos show that sodium tungstate induced structural
and functional remodeling in the hypothalamic circuits, regulating
Figure 5. Sodium tungstate treatment significantly modulates expression of proteins involved in neuronal plasticity. Brains from
mice fed with a standard diet were sliced following 14 days of tungstate treatment and were prepared for immunoreactivity assays. (A) c-fos antibody
reveals an increase in c-fos immunoreactive neurons after tungstate treatment, (B) as does the GFAP antibody. (C) The b-tubulin antibody and (D)
HPC-1 show a decrease in immunoreactive neurons for these proteins. (E) NeuroD-1 immunoreactivity and (F) SNAP25 immunoreactivity increase
after treatment. Scale bar = 50 mM. White and black bars represent untreated and treated animals, respectively. **p,0.01; ***p,0.001. Data are the
mean6SD.
doi:10.1371/journal.pone.0039087.g005
Figure 6. Sodium tungstate modifies neuronal microstructure.
Brains from treated and untreated lean mice were analyzed by MRI. (A)
Sodium tungstate treatment did not alter fractional anisotropy (FA),
neither in the PVN nor in the ARC. In the PVN, treatment decreased: (B)
Main diffusivity (MD); (C) axial diffusivity (AD); and (D) radial diffusivity
(RD). White and black bars represent untreated and treated animals,
respectively. *p,0.05; **p,0.01. Data are the mean6SD.
doi:10.1371/journal.pone.0039087.g006
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food intake, and neuronal activation. Since c-fos immunoreactivity
is not usually elicited by steady state conditions, the elevated levels
of c-fos in the ARC nucleus of the treated animals may reflect
some kind of adaptation involving central food intake regulation,
nutrient absorption, thermogenesis, and fat metabolism or storage
[56,57].
Proteomics and immunohistochemistry results would seem to
indicate some discrepancies for some proteins, i.e. HPC-1,
NeuroD1, SNAP25 or b-tubulin. 2D-DIGE is currently one of
the most powerful quantitative high-throughput proteomics
technologies available [58], which allows for the quantisation of
hundreds and even thousands of proteins under different
conditions at once. Like all non-targeted proteomics technologies,
one of the limitations of all these approaches, both gel-based and
gel-free (LC-MSMS), is that less abundant proteins might be
masked by more abundant ones. In addition, when using 2D, one
protein can be split in several spots (with different mw/pI as
observed in our study), which sometimes make an overall protein
quantification difficult. Thus, the fact that one particular protein
may not be observed in the analyses does not imply that this
protein may be changed under the conditions studied. This could
be the case of b-tubulin in ARC. Another limitation of 2D
electrophoresis is the difficulty in dealing with high and low
molecular weight proteins, extreme pI and hydrophobic mem-
brane proteins. The latter is indeed the case of SNAP25 and HPC-
1, both components of the SNARE complex and membrane and
synaptosome components. Thus, it is likely that these proteins may
not enter in the IPG strip of the 1st dimension of 2D gel.
Nevertheless, HPC-1 was detected by the IPA analysis, which is a
curated database and it is used for validation of proteomics results.
NeuroD1 is a transcription factor and, as with most transcription
factors, it is probably expressed at low concentrations in a whole
tissue homogenate. Therefore, its detection by DIGE and other
non-targeted proteomic approaches is also difficult.
MRI analysis gave us further evidence that sodium tungstate
might actually have a role in neuronal plasticity: changes in water
diffusivity are related with changes in microstructure. FA is
sensitive to water motion along myelinated axons, rather than
perpendicular to them. Since mice brains have little white matter
as compared to human brains, this index is less accurate in rodent
studies. MD is a global measure of water motion, and it increases
after neuronal damage, since edema and loss of neurons involve
higher water content in the tissue. AD reflects diffusion of water
parallel to the axon, while RD reflects diffusion perpendicular to
the axon. Thus, an increase in AD and RD reflects axonal damage
and demyelination, respectively. On the other hand, an increase in
AD and RD has been associated to axonal regeneration and
remyelination [59,60]. Although we could not validate our DTI
findings with histology, based on the other evidences described in
this study, we suggest that the decrease observed in AD and RD
after sodium tungstate treatment in the PVN might reflect
reorganization of the structure possibly related to axonal
sprouting.
The effects of sodium tungstate on neuronal plasticity may have
important implications and potential applications. Animals pre-
disposed to develop obesity on a high-fat diet (which are leptin
resistant) have defective neuronal connections [6,8,61,62]. Leptin
has also been described as playing an important role in neuronal
development and in the projections between the different
hypothalamic nuclei during the early postnatal period, and it has
been described that sodium tungstate acts on leptin pathway [16].
Our proteomic, immunohistochemistry and MRI results give
important clues about possible courses of action of sodium
tungstate on the regulation of energy metabolism, and all these
are promising future outcomes of this treatment. We also open the
door to studying sodium tungstate actions on other neurological
diseases like Alzheimer’s disease.
The fact that sodium tungstate could modulate neural plasticity
in adult animals makes it a suitable and promising candidate for
improving obesity management in adult populations.
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